Free Trial

Curaleaf Q1 2023 Earnings Report

Curaleaf logo
$1.49 +0.02 (+1.36%)
(As of 12/20/2024 05:55 PM ET)

Curaleaf EPS Results

Actual EPS
-$0.05
Consensus EPS
-$0.05
Beat/Miss
Met Expectations
One Year Ago EPS
N/A

Curaleaf Revenue Results

Actual Revenue
$336.50 million
Expected Revenue
$332.21 million
Beat/Miss
Beat by +$4.29 million
YoY Revenue Growth
N/A

Curaleaf Announcement Details

Quarter
Q1 2023
Time
Q1 2023 Earnings Release
Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)

Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.

Click here to watch this demo and decide for yourself.

Curaleaf Earnings Headlines

Cannabis commission OKs first research facility license
2025 AI Stock Picks: 2 Hidden Gems Under $10/Share
The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.
Curaleaf: Start Of A New Era
Curaleaf price target lowered to $5 from $7 at Roth MKM
Curaleaf Holdings (CURLF) Receives a Buy from Roth MKM
See More Curaleaf Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Curaleaf? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Curaleaf and other key companies, straight to your email.

About Curaleaf

Curaleaf (OTCMKTS:CURLF) operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. It also provides hemp-based products and cannabinoids, such as cannabidiol and cannabigerol. In addition, the company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. The company is headquartered in New York, New York.

View Curaleaf Profile

More Earnings Resources from MarketBeat

Upcoming Earnings